Odonate Therapeutics, Inc. (ODT)

Trade ODT now with
11/13/2018 7:03:00 AM Spectrum Appoints Jeffrey Vacirca To Its Board
10/23/2018 8:09:34 AM Odonate Therapeutics Q3 Net Loss $23.9 Mln Or $0.98/Shr Vs $10.4 Mln Or $0.74/Shr Last Year
2/14/2018 8:19:00 AM Odonate Therapeutics Q4 Loss/shr $0.81 Vs. $0.19 Prior Year
1/2/2018 6:09:18 AM Jefferies Starts Odonate Therapeutics, Inc. (ODT) At Buy With $40 Price Target